NR3C1 and rheumatoid arthritis: We identified cyclooxygenase 2 (COX-2) inhibitors, dihydrofolate reductase inhibitors, and glucocorticoid receptor agonists for RA, for which B cells and NK cells are the most enriched cell types with TWAS hits.